Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston blog main
boston top stories
bristol-myers squibb
ifm therapeutics
mark timney
merck
national
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
acadia pharmaceuticals
accent therapeutics
achilles therapeutics
adverum biotechnologies
aimmune
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alk
alnylam pharmaceuticals
alopecia areata
What
drug
pricing
3
×
bio
roundup
aces
advanced
advantages
announced
arrival
award
bar
big
brings
cancer
ceo
cholesterol
data
death
decades
dems
expect
flexible
gamble
given
immunotherapy
inclisiran
key
longer
lowering
lung
market
meant
medco
medco’s
medical
medicine
medicines
mover
nasdaq
new
Language
unset
Current search:
pricing
×
amgen
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
